These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8612234)

  • 1. Auxotrophic vaccines for tuberculosis.
    Guleria I; Teitelbaum R; McAdam RA; Kalpana G; Jacobs WR; Bloom BR
    Nat Med; 1996 Mar; 2(3):334-7. PubMed ID: 8612234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developments.
    Dietrich G; Viret JF; Hess J
    Vaccine; 2003 Jan; 21(7-8):667-70. PubMed ID: 12531337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin.
    Chambers MA; Williams A; Gavier-Widén D; Whelan A; Hall G; Marsh PD; Bloom BR; Jacobs WR; Hewinson RG
    Infect Immun; 2000 Dec; 68(12):7094-9. PubMed ID: 11083835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guérin ΔureC::hly Δpdx1 in mice.
    Gengenbacher M; Vogelzang A; Schuerer S; Lazar D; Kaiser P; Kaufmann SH
    mBio; 2014 Jun; 5(3):e01262-14. PubMed ID: 24895310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant selective drug-resistant M. bovis BCG enhances the bactericidal activity of a second-line anti-tuberculosis regimen.
    Chiwala G; Liu Z; Mugweru JN; Wang B; Khan SA; Bate PNN; Yusuf B; Hameed HMA; Fang C; Tan Y; Guan P; Hu J; Tan S; Liu J; Zhong N; Zhang T
    Biomed Pharmacother; 2021 Oct; 142():112047. PubMed ID: 34426260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mc2-CMX vaccine induces an enhanced immune response against Mycobacterium tuberculosis compared to Bacillus Calmette-Guérin but with similar lung inflammatory effects.
    Oliveira FM; Trentini MM; Junqueira-Kipnis AP; Kipnis A
    Mem Inst Oswaldo Cruz; 2016 Apr; 111(4):223-31. PubMed ID: 27074251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
    Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo persistence and protective efficacy of the bacille Calmette Guerin vaccine overexpressing the HspX latency antigen.
    Spratt JM; Britton WJ; Triccas JA
    Bioeng Bugs; 2010; 1(1):61-5. PubMed ID: 21327127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
    Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S
    Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine against M. tuberculosis.
    Festjens N; Bogaert P; Batni A; Houthuys E; Plets E; Vanderschaeghe D; Laukens B; Asselbergh B; Parthoens E; De Rycke R; Willart MA; Jacques P; Elewaut D; Brouckaert P; Lambrecht BN; Huygen K; Callewaert N
    EMBO Mol Med; 2011 Apr; 3(4):222-34. PubMed ID: 21328541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis.
    Hondalus MK; Bardarov S; Russell R; Chan J; Jacobs WR; Bloom BR
    Infect Immun; 2000 May; 68(5):2888-98. PubMed ID: 10768986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine.
    Jackson M; Phalen SW; Lagranderie M; Ensergueix D; Chavarot P; Marchal G; McMurray DN; Gicquel B; Guilhot C
    Infect Immun; 1999 Jun; 67(6):2867-73. PubMed ID: 10338493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti.
    Pym AS; Brodin P; Brosch R; Huerre M; Cole ST
    Mol Microbiol; 2002 Nov; 46(3):709-17. PubMed ID: 12410828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis.
    Horwitz MA; Harth G
    Infect Immun; 2003 Apr; 71(4):1672-9. PubMed ID: 12654780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCG constitutively expressing the adenylyl cyclase encoded by Rv2212 increases its immunogenicity and reduces replication of M. tuberculosis in lungs of BALB/c mice.
    Pedroza-Roldán C; Marquina-Castillo B; Mata-Espinosa D; Barrios-Payán J; Aceves-Sánchez MJ; Hernández Pando R; Flores-Valdez MA
    Tuberculosis (Edinb); 2018 Dec; 113():19-25. PubMed ID: 30514503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant BCG as a vaccine vehicle to protect against tuberculosis.
    Triccas JA
    Bioeng Bugs; 2010; 1(2):110-5. PubMed ID: 21326936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of live recombinant BCG vaccines.
    Hanson MS; Bansal GP; Langermann S; Stover CK; Orme I
    Dev Biol Stand; 1995; 84():229-36. PubMed ID: 7796958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.